In the clinic, these protumorigenic functions of MDM4 are likely facilitated by the overexpression of the MDM4 gene, which occurs in approximately 20-55% of primary human breast tumors [49, 53, 55, 70]. The gene discussed is MDM4; the disease is breast neoplasm.